Multifaceted Roles of Interleukin-6 in Adipocyte-Breast Cancer Cell Interaction.

Abstract:

:Breast cancer is the most common malignancy in women worldwide, with a developmental process spanning decades. The malignant cells recruit a variety of cells including fibroblasts, endothelial cells, immune cells, and adipocytes, creating the tumor microenvironment. The tumor microenvironment has emerged as active participants in breast cancer progression and response to treatment through autocrine and paracrine interaction with the malignant cells. Adipose tissue is abundant in the breast cancer microenvironment; interactions with cancer cells create cancer-associated adipocytes which produce a variety of adipokines that influence breast cancer initiation, metastasis, angiogenesis, and cachexia. Interleukin (IL)-6 has emerged as key compound significantly produced by breast cancer cells and adipocytes, with the potential of inducing proliferation, epithelial-mesenchymal phenotype, stem cell phenotype, angiogenesis, cachexia, and therapeutic resistance in breast cancer cells. Our aim is to present a brief knowledge of IL-6's role in breast cancer. This review summarizes our current understanding of the breast microenvironment, with emphasis on adipocytes as key players in breast cancer tumorigenesis. The effects of key adipocytes such as leptin, adipokines, TGF-b, and IL-6 are discussed. Finally, we discuss the role of IL-6 in various aspects of cancer progression.

journal_name

Transl Oncol

journal_title

Translational oncology

authors

Gyamfi J,Eom M,Koo JS,Choi J

doi

10.1016/j.tranon.2017.12.009

subject

Has Abstract

pub_date

2018-04-01 00:00:00

pages

275-285

issue

2

issn

1936-5233

pii

S1936-5233(17)30406-0

journal_volume

11

pub_type

杂志文章,评审
  • Contrast Enhancement on Cone-Beam Breast-CT for Discrimination of Breast Cancer Immunohistochemical Subtypes.

    abstract:PURPOSE:To evaluate whether contrast enhancement on cone-beam breast-CT (CBBCT) could aid in discrimination of breast cancer subtypes and receptor status. METHODS:This study included female patients age >40 years with malignant breast lesions identified on contrast-enhanced CBBCT. Contrast enhancement of malignant bre...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2017.08.010

    authors: Uhlig J,Fischer U,von Fintel E,Stahnke V,Perske C,Lotz J,Wienbeck S

    更新日期:2017-12-01 00:00:00

  • Quantification of Regional Breast Density in Four Quadrants Using 3D MRI-A Pilot Study.

    abstract:PURPOSE:This study presented a three-dimensional magnetic resonance (MR)-based method to separate a breast into four quadrants for quantitative measurements of the quadrant breast volume (BV) and density. METHODS:Breast MR images from 58 healthy women were studied. The breast and the fibroglandular tissue were segment...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2015.04.005

    authors: Fwu PT,Chen JH,Li Y,Chan S,Su MY

    更新日期:2015-08-01 00:00:00

  • PLK1, A Potential Target for Cancer Therapy.

    abstract::Polo-like kinase 1 (PLK1) plays an important role in the initiation, maintenance, and completion of mitosis. Dysfunction of PLK1 may promote cancerous transformation and drive its progression. PLK1 overexpression has been found in a variety of human cancers and was associated with poor prognoses in cancers. Many studi...

    journal_title:Translational oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.tranon.2016.10.003

    authors: Liu Z,Sun Q,Wang X

    更新日期:2017-02-01 00:00:00

  • Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation Status.

    abstract::Glioblastoma (GBM) with oligodendroglioma component (GBMO) is a newly described GBM subtype in the 2007 World Health Organization classification. However, its biological and genetic characteristics are largely unknown. We investigated the clinicopathological and molecular features of 34 GBMOs and compared the survival...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2014.10.002

    authors: Myung JK,Cho HJ,Kim H,Park CK,Lee SH,Choi SH,Park P,Yoon JM,Park SH

    更新日期:2014-12-01 00:00:00

  • Comparison of a Concurrent Fluorouracil-Based Regimen and a Taxane-Based Regimen Combined with Radiotherapy in Elderly Patients with Esophageal Squamous Cell Carcinoma.

    abstract::Elderly patients with esophageal carcinoma may benefit from concurrent chemoradiotherapy (CCRT). However, the optimal concurrent chemotherapy regimen has not been determined. The aim of our study was to assess the efficiency and tolerance of treatment with a concurrent 5-fluorouracil (5-Fu)-based regimen and a taxane-...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2019.12.008

    authors: Huang C,Huang D,Zhu Y,Xie G,Wang H,Shi J,Jia B,Yuan Y,Zhang W

    更新日期:2020-03-01 00:00:00

  • Utility of Genomic Analysis in Differentiating Synchronous and Metachronous Lung Adenocarcinomas from Primary Adenocarcinomas with Intrapulmonary Metastasis.

    abstract::Distinguishing synchronous and metachronous primary lung adenocarcinomas from adenocarcinomas with intrapulmonary metastasis is essential for optimal patient management. In this study, multiple lung adenocarcinomas occurring in the same patient were evaluated using comprehensive histopathologic evaluation supplemented...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2017.02.009

    authors: Saab J,Zia H,Mathew S,Kluk M,Narula N,Fernandes H

    更新日期:2017-06-01 00:00:00

  • Loss of PI(4,5)P2 5-Phosphatase A Contributes to Resistance of Human Melanoma Cells to RAF/MEK Inhibitors.

    abstract::Past studies have shown that the inositol polyphosphate 5-phosphatase, phosphatidylinositol 4,5-bisphosphate 5-phosphatase (PIB5PA), is commonly downregulated or lost in melanomas, which contributes to elevated activation of phosphatidylinositol 3-kinase (PI3K)/Akt in melanoma cells. In this report, we provide evidenc...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.13277

    authors: Ye Y,Li Q,Hu WL,Tseng HY,Jin L,Zhang XD,Zhang LJ,Yang S

    更新日期:2013-08-01 00:00:00

  • CBX1 Indicates Poor Outcomes and Exerts Oncogenic Activity in Hepatocellular Carcinoma.

    abstract::Dysregulation of chromobox proteins contributes to the progression of human diseases. CBX1 has been implicated in epigenetic control of chromatin structure and gene expression, but its role in human cancers remains largely unknown. Here we show that CBX1 exhibits oncogenic activities in hepatocellular carcinoma (HCC) ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2018.07.002

    authors: Yang YF,Pan YH,Tian QH,Wu DC,Su SG

    更新日期:2018-10-01 00:00:00

  • Mutations, Differential Gene Expression, and Chimeric Transcripts in Esophageal Squamous Cell Carcinoma Show High Heterogeneity.

    abstract::Esophageal squamous cell carcinoma (ESCC) is a frequent and lethal neoplasia. As recent advances in targeted therapy have not improved ESCC prognosis, characterization of molecular alterations associated to this tumor is of foremost relevance. In this study, we analyze, for the first time, the complete genomic profile...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2018.08.002

    authors: Souza-Santos PT,Soares Lima SC,Nicolau-Neto P,Boroni M,Meireles Da Costa N,Brewer L,Menezes AN,Furtado C,Moreira MAM,Seuanez HN,de Almeida Simão T,Ribeiro Pinto LF

    更新日期:2018-12-01 00:00:00

  • Redox Modulation and Induction of Ferroptosis as a New Therapeutic Strategy in Hepatocellular Carcinoma.

    abstract::Ferroptosis, a newly discovered form of cell death mediated by reactive oxygen species (ROS) and lipid peroxidation, has recently been shown to have an impact on various cancer types; however, so far there are only few studies about its role in hepatocellular carcinoma (HCC). The delicate equilibrium of ROS in cancer ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100785

    authors: Lippmann J,Petri K,Fulda S,Liese J

    更新日期:2020-08-01 00:00:00

  • Control of Glycolytic Flux by AMP-Activated Protein Kinase in Tumor Cells Adapted to Low pH.

    abstract::Tumor cells grow in nutrient- and oxygen-deprived microenvironments and adapt to the suboptimal growth conditions by altering their metabolic pathways. This adaptation process commonly results in a tumor phenotype that displays a high rate of aerobic glycolysis and aggressive tumor characteristics. The glucose regulat...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.11319

    authors: Mendoza EE,Pocceschi MG,Kong X,Leeper DB,Caro J,Limesand KH,Burd R

    更新日期:2012-06-01 00:00:00

  • Ibrutinib is not an effective drug in primografts of TCF3-PBX1.

    abstract:AIM:The Bruton's tyrosine kinase (BTK) inhibitor Ibrutinib (PCI-32765) is effective in patients with multiple myeloma, non-Hodgkin lymphoma and chronic lymphoblastic leukemia. We previously showed that primary cells of children with TCF3-PBX1 positive B-cell precursor acute lymphoblastic leukemia (BCP-ALL) express BTK ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100817

    authors: van de Ven C,Boeree A,Stalpers F,Zwaan CM,Den Boer ML

    更新日期:2020-10-01 00:00:00

  • Enzastaurin, an inhibitor of PKCbeta, Enhances Antiangiogenic Effects and Cytotoxicity of Radiation against Endothelial Cells.

    abstract:PURPOSE:Angiogenesis plays an important role in pancreas cancer pathobiology. Pancreatic tumor cells secrete vascular endothelial growth factor (VEGF), activating endothelial cell protein kinase C beta (PKCbeta) that phosphorylates GSK3beta to suppress apoptosis and promote endothelial cell proliferation and microvesse...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.08151

    authors: Spalding AC,Zeitlin BD,Wilder-Romans K,Davis ME,Nor JE,Lawrence TS,Ben-Josef E

    更新日期:2008-12-01 00:00:00

  • Fatty acid binding protein-4 promotes alcohol-dependent hepatosteatosis and hepatocellular carcinoma progression.

    abstract::Fatty liver disease (hepatosteatosis) is a common early pathology in alcohol-dependent and obese patients. Fatty acid binding protein-4 (FABP4) is normally expressed in adipocytes and macrophages and functions as a regulator of intracellular lipid movement/storage. This study sought to investigate hepatic FABP4 expres...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100975

    authors: Attal N,Sullivan MT,Girardi CA,Thompson KJ,McKillop IH

    更新日期:2021-01-01 00:00:00

  • Antiangiogenic Therapy with Human Apolipoprotein(a) Kringle V and Paclitaxel in a Human Ovarian Cancer Mouse Model.

    abstract:INTRODUCTION:The present study compared the effect of combination therapy using human apolipoprotein(a) kringle V (rhLK8) to conventional chemotherapy with paclitaxel for human ovarian carcinoma producing high or low levels of vascular endothelial growth factor (VEGF). MATERIALS AND METHODS:Human ovarian carcinoma cel...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2014.04.005

    authors: Yu HK,Lee HJ,Yun SJ,Lee SJ,Langley RR,Yoon Y,Yi LS,Bae DS,Kim JS,Kim SJ

    更新日期:2014-06-17 00:00:00

  • Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer.

    abstract::Tumor hypoxia contributes to therapy resistance and metastatic progression of locally advanced rectal cancer (LARC). We postulated that the tumor mitochondrial metabolism, manifested by reactive oxygen species (ROS) and mitochondrial DNA (mtDNA) damage, reflects how hypoxic conditions connect to cancer-induced systemi...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2018.09.010

    authors: Bousquet PA,Meltzer S,Sønstevold L,Esbensen Y,Dueland S,Flatmark K,Sitter B,Bathen TF,Seierstad T,Redalen KR,Eide L,Ree AH

    更新日期:2019-01-01 00:00:00

  • Tumor-suppressor Gene Promoter Hypermethylation in Saliva of Head and Neck Cancer Patients.

    abstract::Head and neck squamous cell carcinoma (HNSCC) accounts for a bulk of the oral and laryngeal cancers, the majority (70%) of which are associated with smoking and excessive drinking, major known risk factors for the development of HNSCC. In contrast to reports that suggest an inverse relationship between smoking and glo...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.12232

    authors: Ovchinnikov DA,Cooper MA,Pandit P,Coman WB,Cooper-White JJ,Keith P,Wolvetang EJ,Slowey PD,Punyadeera C

    更新日期:2012-10-01 00:00:00

  • Colorectal Cancer with Residual Polyp of Origin: A Model of Malignant Transformation.

    abstract::The majority of colorectal cancers (CRCs) arise from adenomatous polyps. In this study, we sought to present the underrecognized CRC with the residual polyp of origin (CRC RPO+) as an entity to be utilized as a model to study colorectal carcinogenesis. We identified all subjects with biopsy-proven CRC RPO+ that were e...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2016.06.002

    authors: Druliner BR,Rashtak S,Ruan X,Bae T,Vasmatzis N,O'Brien D,Johnson R,Felmlee-Devine D,Washechek-Aletto J,Basu N,Liu H,Smyrk T,Abyzov A,Boardman LA

    更新日期:2016-08-01 00:00:00

  • The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine Factors.

    abstract:BACKGROUND AND AIM:Desmoplasia is a characteristic feature and a suspected mechanism of tumor progression in pancreatic ductal adenocarcinoma (PDAC). Main constituents of the stroma involve cancer-associated fibroblasts (CAFs) and extracellular matrix (ECM). The aim of this study was to dissect the interaction of CAFs,...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2017.04.009

    authors: Bolm L,Cigolla S,Wittel UA,Hopt UT,Keck T,Rades D,Bronsert P,Wellner UF

    更新日期:2017-08-01 00:00:00

  • Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease.

    abstract::Hormone receptor positive (HR+) breast cancers are a heterogeneous class with differential prognosis. Although more than half of Indian women present with advanced disease, many such patients do well. We have attempted identification of biologically indolent tumors within HR+HER2- tumors based on gene expression using...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2017.04.011

    authors: Prabhu JS,Korlimarla A,Anupama CE,Alexander A,Raghavan R,Kaul R,Desai K,Rajarajan S,Manjunath S,Correa M,Raman R,Kalamdani A,Prasad M,Patil S,Gopinath KS,Srinath BS,Sridhar TS

    更新日期:2017-08-01 00:00:00

  • Absent in melanoma 2-mediating M1 macrophages facilitate tumor rejection in renal carcinoma.

    abstract::Absent in melanoma 2 (AIM2) as an immune regulator for the regulation of tumor-associated macrophages (TAMs) function is unclear in tumor development. Here, the AIM2 function was investigated in TAMs-mediated malignant behaviors of renal carcinoma. The correlation analysis result showed that the AIM2 expression in TAM...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2021.101018

    authors: Chai D,Zhang Z,Shi SY,Qiu D,Zhang C,Wang G,Fang L,Li H,Tian H,Li H,Zheng J

    更新日期:2021-01-22 00:00:00

  • EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo.

    abstract::ErbB-3 (HER-3) receptor is involved in tumor progression and resistance to therapy. Development of specific inhibitors impairing the activity of ErbB-3 is an attractive tool for cancer therapeutics. MP-RM-1, a murine monoclonal antibody targeting human ErbB-3, has shown anticancer activity in preclinical models. With ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.13475

    authors: Sala G,Rapposelli IG,Ghasemi R,Piccolo E,Traini S,Capone E,Rossi C,Pelliccia A,Di Risio A,D'Egidio M,Tinari N,Muraro R,Iacobelli S,Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO).

    更新日期:2013-12-01 00:00:00

  • CHFR: A Novel Mitotic Checkpoint Protein and Regulator of Tumorigenesis.

    abstract::Checkpoint with FHA and RING finger domains (CHFR) was first recognized as an early mitotic checkpoint protein that delayed the cell cycle in response to microtubule-targeting drugs. It is an E3 ubiquitin ligase that ubiquitinates target proteins to direct them to the proteasome for degradation or to alter their activ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.08109

    authors: Privette LM,Petty EM

    更新日期:2008-07-01 00:00:00

  • Combined Selection System to Lower the Cutoff for Plasma Cell Enrichment Applied to iFISH Analysis in Multiple Myeloma.

    abstract::Multiple myeloma (MM) is a very heterogeneous disease, characterized by multiple cytogenetic aberrations on plasma cells (PC) that have been traditionally used to predict the outcome of the disease. A mayor issue on the analysis of PC is the sometimes low infiltration of these cells in the bone marrow that hampers cyt...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2018.02.021

    authors: Mansilla C,Soria E,Vallejo M,Valiente A,Perez-Juana A,Zabalza A,Hurtado G,Sala F,Ramírez N

    更新日期:2018-06-01 00:00:00

  • A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer.

    abstract:PURPOSE:In the current study we examined the ability of diffusion MRI (dMRI) to predict pathologic response in pancreatic cancer patients receiving neoadjuvant chemoradiation. METHODS:We performed a prospective pilot study of dMRI in patients with resectable pancreatic cancer. Patients underwent dMRI prior to neoadjuv...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2014.07.005

    authors: Cuneo KC,Chenevert TL,Ben-Josef E,Feng MU,Greenson JK,Hussain HK,Simeone DM,Schipper MJ,Anderson MA,Zalupski MM,Al-Hawary M,Galban CJ,Rehemtulla A,Feng FY,Lawrence TS,Ross BD

    更新日期:2014-10-24 00:00:00

  • Pathological Pattern of Intrahepatic HBV in HCC is Phenocopied by PDX-Derived Mice: a Novel Model for Antiviral Treatment.

    abstract:BACKGROUND:Hepatitis B virus (HBV) is one of the most prominent risk factors for hepatocellular carcinoma (HCC) development and virus-mediated cases represents more than 80% of HCC in East Asia, where it is endemic. Currently, the HBV status of pathological HCC is not fully clarified, especially by comparison to nontum...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2019.05.006

    authors: Liu J,Chen S,Zou Z,Tan D,Liu X,Wang X

    更新日期:2019-09-01 00:00:00

  • Interpretation of changes in circulating tumor cell counts.

    abstract::The presence of circulating tumor cells (CTCs) in the blood of cancer patients may guide the use of therapy. We investigated how to evaluate a reduction in the number of CTCs after administration of therapy. CTCs were enumerated with the CellSearch system in 111 metastatic breast and 185 metastatic prostate cancer pat...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.12247

    authors: Coumans FA,Ligthart ST,Terstappen LW

    更新日期:2012-12-01 00:00:00

  • CpG-coated prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastoma.

    abstract::High-risk neuroblastoma, which is associated with regional and systemic metastasis, is a leading cause of cancer-related mortality in children. Responding to this need for novel therapies for high-risk patients, we have developed a "nanoimmunotherapy," which combines photothermal therapy (PTT) using CpG oligodeoxynucl...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100823

    authors: Cano-Mejia J,Shukla A,Ledezma DK,Palmer E,Villagra A,Fernandes R

    更新日期:2020-10-01 00:00:00

  • Nomogram based on preoperative CT imaging predicts the EGFR mutation status in lung adenocarcinoma.

    abstract::Tyrosine kinase inhibitors (TKIs) provide clinical benefits to the lung cancer patients with epidermal growth factor receptor (EGFR) mutations. However, non-invasively determine EGFR mutation status in patients before targeted therapy remains a challenge. This study aimed to develop and validate a nomogram for preoper...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100954

    authors: Zhang G,Zhang J,Cao Y,Zhao Z,Li S,Deng L,Zhou J

    更新日期:2021-01-01 00:00:00

  • Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.

    abstract::BRAFV600-mutated colorectal cancer (CRC) accounts for 8% to 12% of all CRC diagnoses. These tumors are often associated with specific patient features, including right-sided primary tumor location, peritoneal and non-regional lymph node involvement, and poor prognosis. In approximately 30% of cases, a simultaneous mis...

    journal_title:Translational oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.tranon.2020.100795

    authors: Roviello G,D'Angelo A,Petrioli R,Roviello F,Cianchi F,Nobili S,Mini E,Lavacchi D

    更新日期:2020-09-01 00:00:00